In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with two PharmaLex experts about navigating complex R&D ...

Black Opal has been offering cosmetics targeted to black and brown skin tones for over three decades. China Glaze is a nail ...

Walgreens has sold more shares of drug distributor Cencora for proceeds of about $300 million in the latest effort to pay ...

Hello, and welcome, everyone, to the Cencora Q1 fiscal year 2025 earnings call. My name is Becky, and I'll be your operator today. (Operator Instructions) I will now hand over to your host, Head of ...

Q1 2025. Management View. CEO Robert Mauch highlighted strong Q1 performance with 13% revenue growth and a 14% increase in adjusted EPS.

Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2025 first quarter ended December 31, 2024, revenue increased 12.8 percent year-over-year to $81.5 billion. On the basis of U.S. generally ...

Many Chief Information Security Officers (CISOs) aim to enhance their crisis simulation capabilities in 2025 with the aim to prepare for potential full-scale cyber crises, according to a new study by ...

Funded by the Gates Foundation, MSD, Cencora, Endless Foundation, HELP Logistics (a subsidiary of the Kühne Foundation), ...

Shares of Cencora Inc. COR shed 1.64% to $254.21 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.50% to 6,040.53 and ...

Cencora is one of the world's largest pharmaceutical ... Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money ...

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at where Cencora, Inc. (NYSE:COR) stands against the other stocks Jim Cramer ...